Refresh for latest…: Lionsgate’s third outing with the Four Horsemen conjured a $75.5M global opening this weekend. Of that, $54.2M was in 64 international box office markets. The magic extended to No ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...
Clockwise from top left: 'Superman,' 'A Minecraft Movie,' 'Sinners,' 'F1' and 'Weapons' Warner Bros. EXCLUSIVE: Just as Warner Bros is opening its seventh original movie this year with Paul Thomas ...
You’ve got enough on your plate–work, workouts, nights, and everything in between. What you don’t have time for is trying out hundreds of so-so products just to find the one needle in the proverbial ...
All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Gizmodo may earn an affiliate commission. Reading time 2 minutes ...
McDonald’s is slashing the prices of its combo meals just a few weeks after the CEO publicly admitted that its menu has gotten too expensive and pledged to fix the problem. McDonald’s and its US ...
Rahul Malhotra is a Weekend News Writer for Collider. From Francois Ozon to David Fincher, he'll watch anything once. He has been writing for Collider for over two years, and has covered everything ...
Box Office: ‘Bad Guys 2,’ ‘Naked Gun’ Scoring Solid Openings as ‘Fantastic Four’ Stays No. 1 Overall
Neon's indie horror-comedy 'Together' is also opening this weekend at the crowded domestic box office. By Pamela McClintock Senior Film Writer What better way to go out than to go out laughing.
AbbVie seeks FDA approval for Venclexta and Calquence combination for untreated CLL, following positive AMPLIFY trial results. The combination regimen showed a 35% reduction in disease progression or ...
Diego is a writer and editor with over six years of experience covering games. He's mainly focused on guides, but he's done reviews, features, news, and everything in between. A fan of all genres, you ...
A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for success to tee up a filing for FDA approval in the fourth quarter. The study ...
President Trump is lashing out at his supporters amid their ongoing anger over his administration’s handling of the investigation into convicted sex offender Jeffrey Epstein. In a Truth Social post ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback